HeartSciences Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 3.61 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 17.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Details
| Name | HeartSciences Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 14 |
| Founded | 2007 |
| Ipo Date | 2022-06-15 |
| Ceo | Andrew Simpson |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| Ipo Price | 4.25 |
| Isin | US42254E3027 |
| Cusip | 42254E302 |
| Cik | 1468492 |
| Sic | 6199 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Andrew Simpson | Chief Executive Officer, President and Chairman of the Board of Directors |
| Danielle Watson | Chief Financial Officer and Treasurer |
Contact
| Address | 550 Reserve Street, Suite 360, Southlake, Texas 76092, United States |
| Phone | 682 237 7781 |
| Website | https://heartsciences.com |